Commonwealth legislation

Customs By-law No. 2200083

In ForceCTH

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

3/10 complexity

This by-law prescribes certain active ingredients as the kind of goods covered by item 57 of Schedule 4 to the Customs Tariff Act 1995. Mechanically, it identifies inputs used to manufacture Chapter 30 medicaments and vaccines that are intended for the treatment, prevention or limitation of COVID‑19. It affects importers and manufacturers of those active ingredients by clarifying which imports qualify under item 57 for tariff treatment and by excluding finished medicament products already manufactured into Chapter 30 goods. Commencement: 1 July 2022.

JSON API

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in Customs By-law No. 2200083.

Customs By-law No. 2200083

CUSTOMS ACT 1901

CUSTOMS TARIFF ACT 1995

SCHEDULE 4

BY-LAW No. 2200083

I, Franco Alvarez, delegate of the Comptroller‑General of Customs, under section 271 of the Customs Act 1901, make the by-law set out in the Schedule to this instrument.

This by-law commences on 1 July 2022.

Dated this 28th day of June 2022.

[signed]

Franco Alvarez

Delegate of the

Comptroller-General of Customs

SCHEDULE

Item 57

Schedule 4

This by-law may be cited as Customs By-law No. 2200083.
For the purposes of item 57 of Schedule 4 to the Customs Tariff Act 1995 (the Customs Tariff), goods of the following kind are prescribed:

(a) the goods are active ingredients to be used in the manufacture of medicaments, vaccines and other goods (the manufactured goods);

(b) the manufactured goods, if imported, would be classified under Chapter 30 of Schedule 3 to the Customs Tariff; and

(c) the manufactured goods are to be used in the treatment, prevention or to limit the severity of the disease known as COVID‑19.

For the purposes of paragraph 2, active ingredients means only those ingredients that give the manufactured goods their therapeutic or prophylactic effect.
For the avoidance of doubt, paragraph 2 does not apply if the active ingredients have already been manufactured into the final product of a medicament, vaccine or other good that, if imported, would be classified under Chapter 30.
In this by-law, the Customs Tariff Act 1995 means the Customs Tariff Act 1995, as amended or proposed to be altered.

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

1 Customs By-law No. 2200083